• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以 5-氟-7H-吡咯并[2,3-d]嘧啶为骨架的 FAK 抑制剂的合成与评价及其作为抗肝癌药物的研究。

Synthesis and evaluation of FAK inhibitors with a 5-fluoro-7H-pyrrolo[2,3-d]pyrimidine scaffold as anti-hepatocellular carcinoma agents.

机构信息

Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai, 201203, China.

Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Centre for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, 200240, China.

出版信息

Eur J Med Chem. 2021 Nov 5;223:113670. doi: 10.1016/j.ejmech.2021.113670. Epub 2021 Jun 25.

DOI:10.1016/j.ejmech.2021.113670
PMID:34214842
Abstract

Focal adhesion kinase (FAK) is a ubiquitous intracellular non-receptor tyrosine kinase, which is involved in multiple cellular functions, including cell adhesion, migration, invasion, survival, and angiogenesis. In this study, a series of 7H-pyrrolo[2,3-d]pyrimidines were designed and synthesized according to the E-pharmacophores generated by docking a library of 667 fragments into the ATP pocket of the co-crystal complex of FAK and PF-562271 (PDB ID: 3BZ3). The 5-fluoro-7H-pyrrolo[2,3-d]pyrimidine derivatives demonstrated excellent activity against FAK and the cell lines SMMC7721 and YY8103. 2-((2-((3-(Acetamidomethyl)phenyl)amino)-5-fluoro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-methylbenzamide (16c) was selected for further bioactivity evaluations in vivo, including preliminary pharmacokinetic profiling in rats and toxicity assays in mice, and tumor growth inhibition studies in a xenograft tumor model. The results showed that 16c did not affect the body weight gain of the animals up to a dose of 200 mg/kg, and significantly inhibited tumor growth with a tumor growth inhibition rate of 78.6% compared with the negative control group. Furthermore, phosphoantibody array analyses of a sample of the tumor suggested that 16c inhibited the malignant proliferation of hepatocellular carcinoma (HCC) cells through decreasing the phosphorylation in the FAK cascade.

摘要

黏着斑激酶(FAK)是一种普遍存在的细胞内非受体酪氨酸激酶,参与多种细胞功能,包括细胞黏附、迁移、侵袭、存活和血管生成。在这项研究中,根据将 667 个片段库对接入 FAK 和 PF-562271(PDB ID:3BZ3)共晶复合物的 ATP 口袋中产生的 E-药效团,设计并合成了一系列 7H-吡咯并[2,3-d]嘧啶。5-氟-7H-吡咯并[2,3-d]嘧啶衍生物对 FAK 和 SMMC7721 和 YY8103 细胞系表现出优异的活性。2-((2-((3-(乙酰氨甲基)苯基)氨基)-5-氟-7H-吡咯并[2,3-d]嘧啶-4-基)氨基)-N-甲基苯甲酰胺(16c)被选为进一步的体内生物活性评估,包括在大鼠中的初步药代动力学特征研究和在小鼠中的毒性试验,以及在异种移植肿瘤模型中的肿瘤生长抑制研究。结果表明,16c 高达 200mg/kg 的剂量不会影响动物的体重增加,并与阴性对照组相比,显著抑制肿瘤生长,肿瘤生长抑制率为 78.6%。此外,肿瘤样本的磷酸化抗体阵列分析表明,16c 通过降低 FAK 级联中的磷酸化来抑制肝癌(HCC)细胞的恶性增殖。

相似文献

1
Synthesis and evaluation of FAK inhibitors with a 5-fluoro-7H-pyrrolo[2,3-d]pyrimidine scaffold as anti-hepatocellular carcinoma agents.以 5-氟-7H-吡咯并[2,3-d]嘧啶为骨架的 FAK 抑制剂的合成与评价及其作为抗肝癌药物的研究。
Eur J Med Chem. 2021 Nov 5;223:113670. doi: 10.1016/j.ejmech.2021.113670. Epub 2021 Jun 25.
2
Discovery of 7H-pyrrolo[2,3-d]pyridine derivatives as potent FAK inhibitors: Design, synthesis, biological evaluation and molecular docking study.发现 7H-吡咯并[2,3-d]嘧啶衍生物作为有效的 FAK 抑制剂:设计、合成、生物评价和分子对接研究。
Bioorg Chem. 2020 Sep;102:104092. doi: 10.1016/j.bioorg.2020.104092. Epub 2020 Jul 14.
3
Design, synthesis and biological evaluation of novel 7H-pyrrolo[2,3-d]pyrimidine derivatives as potential FAK inhibitors and anticancer agents.新型 7H-吡咯并[2,3-d]嘧啶衍生物的设计、合成及作为潜在 FAK 抑制剂和抗癌剂的生物评价。
Eur J Med Chem. 2019 Dec 1;183:111716. doi: 10.1016/j.ejmech.2019.111716. Epub 2019 Sep 18.
4
Design, synthesis and biological evaluation of 7-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)-2,3-dihydro-1H-inden-1-one derivatives as potent FAK inhibitors for the treatment of ovarian cancer.设计、合成及生物评价 7-((7H-吡咯并[2,3-d]嘧啶-4-基)氧基)-2,3-二氢-1H-茚-1-酮衍生物作为潜在的卵巢癌治疗用 FAK 抑制剂。
Eur J Med Chem. 2022 Jan 15;228:113978. doi: 10.1016/j.ejmech.2021.113978. Epub 2021 Nov 11.
5
N⁴-(3-Bromophenyl)-7-(substituted benzyl) pyrrolo[2,3-d]pyrimidines as potent multiple receptor tyrosine kinase inhibitors: design, synthesis, and in vivo evaluation.N⁴-(3-溴苯基)-7-(取代苄基)吡咯并[2,3-d]嘧啶作为有效的多受体酪氨酸激酶抑制剂的设计、合成及体内评价。
Bioorg Med Chem. 2012 Apr 1;20(7):2444-54. doi: 10.1016/j.bmc.2012.01.029. Epub 2012 Feb 4.
6
Design and synthesis of 7H-pyrrolo[2,3-d]pyrimidines as focal adhesion kinase inhibitors. Part 1.作为粘着斑激酶抑制剂的7H-吡咯并[2,3-d]嘧啶的设计与合成。第1部分。
Bioorg Med Chem Lett. 2006 Apr 15;16(8):2173-6. doi: 10.1016/j.bmcl.2006.01.053. Epub 2006 Feb 3.
7
Identification of Pyrrolo[2,3- d]pyrimidine-Based Derivatives as Potent and Orally Effective Fms-like Tyrosine Receptor Kinase 3 (FLT3) Inhibitors for Treating Acute Myelogenous Leukemia.鉴定吡咯并[2,3- d]嘧啶类衍生物作为有效且可口服的 Fms 样酪氨酸激酶 3(FLT3)抑制剂用于治疗急性髓系白血病。
J Med Chem. 2019 Apr 25;62(8):4158-4173. doi: 10.1021/acs.jmedchem.9b00223. Epub 2019 Apr 15.
8
X-ray Crystal Structure-Guided Design and Optimization of 7-Pyrrolo[2,3-]pyrimidine-5-carbonitrile Scaffold as a Potent and Orally Active Monopolar Spindle 1 Inhibitor.基于X射线晶体结构的7-吡咯并[2,3-]嘧啶-5-腈骨架的设计与优化:一种强效且口服活性的单极纺锤体1抑制剂
J Med Chem. 2021 May 27;64(10):6985-6995. doi: 10.1021/acs.jmedchem.1c00542. Epub 2021 May 4.
9
Design, synthesis and biological evaluation of substituted pyrrolo[2,3-d]pyrimidines as multiple receptor tyrosine kinase inhibitors and antiangiogenic agents.作为多受体酪氨酸激酶抑制剂和抗血管生成剂的取代吡咯并[2,3-d]嘧啶的设计、合成及生物学评价
Bioorg Med Chem. 2008 May 15;16(10):5514-28. doi: 10.1016/j.bmc.2008.04.019. Epub 2008 Apr 14.
10
Synthesis, biological evaluation, and molecular dynamics (MD) simulation studies of three novel F-18 labeled and focal adhesion kinase (FAK) targeted 5-bromo pyrimidines as radiotracers for tumor.三种新型 F-18 标记的嘧啶类化合物和粘着斑激酶(FAK)靶向物的合成、生物评价及分子动力学(MD)模拟研究作为肿瘤放射性示踪剂。
Eur J Med Chem. 2017 Feb 15;127:493-508. doi: 10.1016/j.ejmech.2017.01.015. Epub 2017 Jan 11.

引用本文的文献

1
Recent advances in the antimicrobial application of the pyrrolo[2,3-]pyrimidine scaffold: innovative synthetic strategies, structural diversification, and bioactivity evaluation.吡咯并[2,3 - ]嘧啶骨架在抗菌应用方面的最新进展:创新的合成策略、结构多样化及生物活性评估
RSC Adv. 2025 Aug 26;15(36):29627-29645. doi: 10.1039/d5ra03313f. eCollection 2025 Aug 18.
2
FAK signaling suppression by OCT4-ITGA6 mediates the effectively removal of residual pluripotent stem cells and enhances application safety.OCT4-ITGA6对粘着斑激酶信号的抑制介导了残留多能干细胞的有效清除并提高了应用安全性。
Theranostics. 2025 Jun 12;15(14):7127-7153. doi: 10.7150/thno.111198. eCollection 2025.
3
Recent advances in focal adhesion kinase (FAK)-targeting antitumor agents.
聚焦粘附激酶(FAK)靶向抗肿瘤药物的最新进展。
RSC Adv. 2025 Jun 20;15(26):20957-20984. doi: 10.1039/d5ra01880c. eCollection 2025 Jun 16.
4
Design, synthesis and antitumor activity of 4-indazolylpyrimidine derivatives as EGFR inhibitors.作为表皮生长因子受体(EGFR)抑制剂的4-吲唑基嘧啶衍生物的设计、合成及抗肿瘤活性
Mol Divers. 2024 Dec 3. doi: 10.1007/s11030-024-11052-y.
5
Pyrrolo[2,3-D]Pyrimidines as EGFR and VEGFR Kinase Inhibitors: A Comprehensive SAR Review.吡咯并[2,3-d]嘧啶作为 EGFR 和 VEGFR 激酶抑制剂:全面的 SAR 综述。
Curr Med Chem. 2024;31(36):5918-5936. doi: 10.2174/0929867331666230815115111.
6
The Development of FAK Inhibitors: A Five-Year Update.FAK 抑制剂的研发进展:五年回顾。
Int J Mol Sci. 2022 Jun 7;23(12):6381. doi: 10.3390/ijms23126381.